Chimeric antigen receptor T-cell (CAR-T) therapy, whereby autologous T cells are genetically engineered to recognize and eliminate tumor cells in vivo, has revolutionized cancer care since the first ...

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...

Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR ...

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...

Chimeric antigen receptor T cells (CAR-Ts) targeted against CD19 have shown impressive activity in patients with B-cell leukemias and lymphomas. This has revolutionized the treatment landscape for ...

The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of autologous anti-CD19 CAR T-cells.